Get the Stockscreener App
1.20
4.00%
-0.05
After Hours:
1.28
0.08
+6.67%
Repare Therapeutics Inc Stock (RPTX) Forecast
The Repare Therapeutics Inc (RPTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.5622, representing a +446.85% increase from the current price of $1.20. The highest analyst price target is $9.1872, and the lowest is $3.9372.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RPTX Price Target
Average 7.7317
(+544.31% Upside)
Is Repare Therapeutics Inc (RPTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.56 | Neutral |
| STOCH(9,6) | 65.72 | Neutral |
| STOCHRSI(14) | 56.89 | Neutral |
| MACD(12,26) | -0.1328 | Buy |
| ADX(14) | 23.79 | Neutral |
| William %R | -54.55 | Neutral |
| CCI(14) | 16.40 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.204
Sell
|
1.2271
Sell
|
| MA20 |
1.2365
Sell
|
1.289
Sell
|
| MA50 |
1.7994
Sell
|
1.7277
Sell
|
| MA100 |
2.5956
Sell
|
2.2886
Sell
|
| MA200 |
2.9875
Sell
|
3.1329
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RPTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on RPTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.56 indicates that RPTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.72 indicates that RPTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.89 indicates that RPTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.79 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 16.4 indicates that RPTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RPTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Repare Therapeutics Inc financial reports and earnings history, Repare Therapeutics Inc (RPTX) stock could reach $6.1979 by 2030, $43.27 by 2040 and $33.84 by 2050. See the projected annual prices until 2050 of the Repare Therapeutics Inc stock below:
- Repare Therapeutics Inc (RPTX) is expected to reach an average price of $36.05 in 2035, with a high prediction of $35.99 and a low estimate of $35.73. This indicates an $2,904% rise from the last recorded price of $1.20.
- Repare Therapeutics Inc (RPTX) stock is projected to chart a bullish course in 2040, with an average price target of $41.95, representing an $3,396% surge from its current level. The forecast ranges from a conservative $43.06 to a sky-high $43.27.
- Our analysts predict Repare Therapeutics Inc (RPTX) to jump 3,384% by 2045, soaring from $41.93 to an average price of $41.81, potentially reaching $41.93. While $41.93 is the low estimate, the potential upside is significant.
- Repare Therapeutics Inc (RPTX) stock is expected to climb by 2050, reaching an average of $29.83, a $2,386% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.84 and $31.86, respectively, highlighting the market's uncertainty.
Repare Therapeutics Inc Stock (RPTX) Year by Year Forecast
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2025
Repare Therapeutics Inc Stock (RPTX) is expected to reach an average price of $11.19 in 2025, with a high prediction of $22.12 and a low estimate of $0.2699. This indicates an +832.90% rise from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $7.5107 | $3.9372 | $9.1872 | +525.89% |
| April, 2025 | $11.01 | $6.8775 | $12.69 | +817.87% |
| May, 2025 | $9.4315 | $8.1512 | $13.53 | +685.96% |
| June, 2025 | $9.9785 | $8.8883 | $14.41 | +731.54% |
| July, 2025 | $12.73 | $7.9188 | $14.53 | +961.02% |
| August, 2025 | $13.50 | $11.05 | $15.30 | +1,025% |
| September, 2025 | $11.69 | $10.23 | $14.95 | +873.86% |
| October, 2025 | $2.7801 | $0.2699 | $11.48 | +131.68% |
| November, 2025 | $9.2571 | $1.5369 | $9.2771 | +671.43% |
| December, 2025 | $1.9909 | $1.3409 | $9.4989 | +65.91% |
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2026
The predicted value for Repare Therapeutics Inc (RPTX) in 2026 is set at an average of $3.2028. Estimates vary from a peak of $6.3035 to a trough of $0.1021, indicating an +166.90% surge from the present price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2321 | $0.1677 | $5.5944 | +2.67% |
| February, 2026 | $2.0351 | $3.0051 | $2.1036 | +69.59% |
| March, 2026 | $1.668 | $2.858 | $1.7048 | +39.00% |
| April, 2026 | $3.3443 | $1.8713 | $2.236 | +178.69% |
| May, 2026 | $4.6073 | $2.0808 | $3.5073 | +283.94% |
| June, 2026 | $6.8902 | $4.9637 | $4.5502 | +474.19% |
| July, 2026 | $1.3265 | $2.5365 | $6.3035 | +10.54% |
| August, 2026 | $0.7494 | $1.2494 | $0.6847 | -37.55% |
| September, 2026 | $1.6257 | $0.6309 | $1.6573 | +35.47% |
| October, 2026 | $1.8086 | $2.0754 | $1.4786 | +50.72% |
| November, 2026 | $1.3016 | $1.3784 | $0.5616 | +8.47% |
| December, 2026 | $2.8421 | $0.1021 | $2.8521 | +136.85% |
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Repare Therapeutics Inc (RPTX) is $3.1743, with a high forecast of $6.3392 and a low forecast of $0.00952. This indicates an +164.53% increase from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.7892 | $1.1957 | $6.3392 | +382.43% |
| February, 2027 | $3.8062 | $2.5959 | $5.9062 | +217.18% |
| March, 2027 | $1.47 | $0.30 | $4.6129 | +22.50% |
| April, 2027 | $1.407 | $0.2991 | $2.467 | +17.25% |
| May, 2027 | $0.276 | $0.00952 | $2.8437 | -77.00% |
| June, 2027 | $0.1522 | $0.2493 | $0.9407 | -87.31% |
| July, 2027 | $0.6052 | $0.722 | $0.418 | -49.57% |
| August, 2027 | $1.1618 | $0.2718 | $1.7818 | -3.18% |
| September, 2027 | $2.8156 | $1.1986 | $4.8555 | +134.63% |
| October, 2027 | $2.4926 | $1.7823 | $3.6526 | +107.72% |
| November, 2027 | $1.9896 | $0.2696 | $2.8095 | +65.80% |
| December, 2027 | $3.2834 | $1.3764 | $3.3834 | +173.62% |
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2028
In 2028, Repare Therapeutics Inc (RPTX) is projected to reach an average price of $14.95, with a high projection of $29.86 and a low estimate of $0.0368. This indicates an +1,146% rise from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9654 | $0.7754 | $6.8469 | -19.55% |
| February, 2028 | $2.9626 | $1.5728 | $2.8026 | +146.88% |
| March, 2028 | $0.6788 | $1.2088 | $2.1858 | -43.43% |
| April, 2028 | $1.4482 | $0.3415 | $1.6715 | +20.68% |
| May, 2028 | $1.652 | $0.7452 | $2.525 | +37.67% |
| June, 2028 | $2.189 | $1.2987 | $4.049 | +82.42% |
| July, 2028 | $1.836 | $1.566 | $3.3293 | +53.00% |
| August, 2028 | $0.1698 | $0.1298 | $2.1228 | -85.85% |
| September, 2028 | $0.2418 | $0.0368 | $0.4468 | -79.85% |
| October, 2028 | $25.22 | $24.07 | $23.21 | +2,002% |
| November, 2028 | $28.57 | $29.14 | $29.86 | +2,281% |
| December, 2028 | $27.70 | $28.52 | $27.65 | +2,208% |
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2029
The 2029 price forecast for Repare Therapeutics Inc Stock (RPTX) is $15.75 on average, with a high prediction of $23.75 and a low estimate of $7.7407. This represents an +1,212% increase from the previous price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.60 | $21.02 | $21.45 | +1,617% |
| February, 2029 | $23.04 | $24.60 | $23.75 | +1,820% |
| March, 2029 | $19.19 | $22.53 | $22.41 | +1,499% |
| April, 2029 | $12.44 | $14.06 | $18.87 | +936.52% |
| May, 2029 | $6.2407 | $7.7407 | $13.76 | +420.06% |
| June, 2029 | $12.11 | $11.11 | $8.8966 | +908.89% |
| July, 2029 | $18.28 | $15.17 | $17.18 | +1,424% |
| August, 2029 | $14.19 | $15.61 | $16.43 | +1,082% |
| September, 2029 | $11.04 | $12.73 | $10.80 | +820.09% |
| October, 2029 | $9.6135 | $11.52 | $10.28 | +701.12% |
| November, 2029 | $11.10 | $10.62 | $10.36 | +824.95% |
| December, 2029 | $7.9354 | $8.9904 | $8.7699 | +561.28% |
Repare Therapeutics Inc Stock (RPTX) Price Forecast for 2030
Repare Therapeutics Inc Stock (RPTX) is expected to reach an average price of $14.35 in 2030, with a high forecast of $21.85 and a low forecast of $6.8442. This signifies an +1,095% surge from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.2679 | $7.2584 | $6.1979 | +422.32% |
| February, 2030 | $11.78 | $6.8442 | $8.2238 | +881.98% |
| March, 2030 | $16.50 | $13.66 | $16.00 | +1,275% |
| April, 2030 | $9.5957 | $11.95 | $13.53 | +699.65% |
| May, 2030 | $16.33 | $11.27 | $13.16 | +1,261% |
| June, 2030 | $19.12 | $15.89 | $14.77 | +1,494% |
| July, 2030 | $20.12 | $20.47 | $19.78 | +1,576% |
| August, 2030 | $17.79 | $18.80 | $18.85 | +1,383% |
| September, 2030 | $19.85 | $19.39 | $18.85 | +1,554% |
| October, 2030 | $20.26 | $18.37 | $19.76 | +1,588% |
| November, 2030 | $22.64 | $20.83 | $21.85 | +1,786% |
| December, 2030 | $16.44 | $17.65 | $21.26 | +1,270% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):